Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: a retrospective multicenter study

MS Dal, H Batgi, MA Erkurt, IY Hindilerden… - … and Apheresis Science, 2021 - Elsevier
Extracorporeal photopheresis (ECP) is a treatment strategy in steroid-refractory chronic
graft-versus-host disease (… experience using ECP in our steroid-refractory cGvHD patients. …

[HTML][HTML] Retrospective multicenter study of extracorporeal photopheresis in steroid-refractory acute and chronic graft-versus-host disease

G Oarbeascoa, ML Lozano, LM Guerra… - Biology of Blood and …, 2020 - Elsevier
Extracorporeal photopheresis (ECP) is an established treatment strategy in steroid-refractory
graft-versus-host disease (GVHD… A retrospective observational series of 113 patients from 7 …

Extracorporeal photopheresis for treatment of acute and chronic graft versus host disease: an Italian multicentric retrospective analysis on 94 patients on behalf of the …

M Malagola, V Cancelli, C Skert, PF Leali… - …, 2016 - journals.lww.com
… The great majority of the data published on ECP for the treatment of steroid-refractory aGVHD
… Given this background, we report here on a multicenter retrospective observational Italian …

[HTML][HTML] Extracorporeal photopheresis in acute and chronic steroidrefractory graft-versus-host disease: an evolving treatment landscape

HT Greinix, F Ayuk, R Zeiser - Leukemia, 2022 - nature.com
Patients with steroid-refractory graft-versus-host disease (GvHD) are known to have a poor
prognosis and for decades no approved drug has been available to treat this serious …

… centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid …

SM Linn, I Novitzky-Basso, C Patriquin, I Pasic… - Leukemia Research, 2023 - Elsevier
Chronic graft-versus-host disease (cGvHD) is one of the frequently occurring but highly
significant complications related to allogeneic Hematopoietic cell transplant (HCT) [1]: it is one of …

Extracorporeal photopheresis in graft-versus-host disease

B Drexler, A Buser, L Infanti, G Stehle, J Halter… - Transfusion Medicine …, 2020 - karger.com
Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute
graft-versushost disease: a … photochemotherapy: a retrospective study according to classical and …

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

E Kansu, D Ward, AP Sanchez, R Cunard, M Hayran… - …, 2022 - Taylor & Francis
… a retrospective review of ECP in 32 steroid-dependent or steroid refractory chronic GVHD
patients … steroid-refractory or steroid-intolerant chronic GVHD patients with progressive onset of …

Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)

L Kaynar, E Tekgunduz, I Kozanoglu, HA Ozkan… - … and Apheresis Science, 2022 - Elsevier
… in the treatment of both acute and chronic steroid refractory GVHD as it does not increase …
retrospective and observational studies repeatedly support efficacy of ECP in steroid-refractory

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

J Schneiderman - Hematology 2014, the American Society of …, 2017 - ashpublications.org
… The retrospective nature of this study led to significant … a total of 323 patients with
steroid-refractory or steroid-dependent … reflect that patients with steroid-refractory or …

Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease—experience with three different …

M Nygaard, T Karlsmark, NS Andersen… - Bone Marrow …, 2019 - nature.com
… It is well recognized that patients with steroid-refractory aGvHD are at high risk of severe or
fatal infections [12]. This study is limited by its retrospective nature, the small sample size, and …